DELTA APPAREL INC (DLA)

US2473681037 - Common Stock

0.58  +0.08 (+16%)

Premarket: 0.4478 -0.13 (-22.79%)

Fundamental Rating

2

Taking everything into account, DLA scores 2 out of 10 in our fundamental rating. DLA was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of DLA have multiple concerns. DLA does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year DLA has reported negative net income.
DLA had a positive operating cash flow in the past year.
In multiple years DLA reported negative net income over the last 5 years.
DLA had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -18.44%, DLA is doing worse than 84.00% of the companies in the same industry.
DLA has a Return On Equity of -63.26%. This is amonst the worse of the industry: DLA underperforms 86.00% of its industry peers.
Industry RankSector Rank
ROA -18.44%
ROE -63.26%
ROIC N/A
ROA(3y)0.38%
ROA(5y)0.16%
ROE(3y)0.36%
ROE(5y)-0.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DLA has a Gross Margin of 10.18%. This is amonst the worse of the industry: DLA underperforms 96.00% of its industry peers.
In the last couple of years the Gross Margin of DLA has declined.
DLA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.18%
GM growth 5Y-8.91%

3

2. Health

2.1 Basic Checks

DLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
DLA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DLA has been increased compared to 5 years ago.
Compared to 1 year ago, DLA has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that DLA is in the distress zone and has some risk of bankruptcy.
DLA has a worse Altman-Z score (1.03) than 76.00% of its industry peers.
DLA has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
DLA has a Debt to FCF ratio of 1.98. This is comparable to the rest of the industry: DLA outperforms 60.00% of its industry peers.
DLA has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
DLA has a Debt to Equity ratio of 0.15. This is in the better half of the industry: DLA outperforms 64.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.98
Altman-Z 1.03
ROIC/WACCN/A
WACC6.87%

2.3 Liquidity

DLA has a Current Ratio of 1.01. This is a normal value and indicates that DLA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.01, DLA is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
DLA has a Quick Ratio of 1.01. This is a bad value and indicates that DLA is not financially healthy enough and could expect problems in meeting its short term obligations.
DLA has a Quick ratio of 0.21. This is amonst the worse of the industry: DLA underperforms 98.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.21

2

3. Growth

3.1 Past

DLA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -423.30%.
DLA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.49%.
DLA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.99% yearly.
EPS 1Y (TTM)-423.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-153%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y2.92%
Revenue growth 5Y0.99%
Sales Q2Q%-28.45%

3.2 Future

Based on estimates for the next years, DLA will show a very strong growth in Earnings Per Share. The EPS will grow by 34.37% on average per year.
The Revenue is expected to decrease by -3.00% on average over the next years.
EPS Next Y34.98%
EPS Next 2Y34.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.35%
Revenue Next 2Y-3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

DLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

DLA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DLA is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA N/A

4.3 Compensation for Growth

DLA's earnings are expected to grow with 34.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.37%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DELTA APPAREL INC

NYSEARCA:DLA (6/28/2024, 7:04:00 PM)

Premarket: 0.4478 -0.13 (-22.79%)

0.58

+0.08 (+16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.09M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.44%
ROE -63.26%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 10.18%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.01
Quick Ratio 0.21
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-423.3%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y34.98%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y2.92%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y